- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x LNK: PENTANE(Non-covalent)
LNK.5: 1 residues within 4Å:- Chain A: S.415
No protein-ligand interaction detected (PLIP)LNK.13: 2 residues within 4Å:- Chain B: S.415, M.419
No protein-ligand interaction detected (PLIP)LNK.21: 1 residues within 4Å:- Chain C: S.415
No protein-ligand interaction detected (PLIP)LNK.27: 1 residues within 4Å:- Chain D: S.415
No protein-ligand interaction detected (PLIP)- 8 x OCT: N-OCTANE(Non-covalent)
OCT.6: 1 residues within 4Å:- Chain A: S.415
No protein-ligand interaction detected (PLIP)OCT.7: 2 residues within 4Å:- Chain A: G.401, W.402
No protein-ligand interaction detected (PLIP)OCT.14: 1 residues within 4Å:- Chain B: S.415
No protein-ligand interaction detected (PLIP)OCT.15: 2 residues within 4Å:- Chain B: G.401, W.402
No protein-ligand interaction detected (PLIP)OCT.22: 1 residues within 4Å:- Chain C: S.415
No protein-ligand interaction detected (PLIP)OCT.23: 2 residues within 4Å:- Chain C: G.401, W.402
No protein-ligand interaction detected (PLIP)OCT.28: 1 residues within 4Å:- Chain D: S.415
No protein-ligand interaction detected (PLIP)OCT.29: 2 residues within 4Å:- Chain D: G.401, W.402
No protein-ligand interaction detected (PLIP)- 4 x R16: HEXADECANE(Non-covalent)
R16.8: 6 residues within 4Å:- Chain A: L.485, S.504, L.505, S.506
- Chain D: Q.532
- Ligands: 01.11
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.485, A:L.485, A:L.505
R16.12: 6 residues within 4Å:- Chain A: Q.532
- Chain C: L.485, S.504, L.505, S.506
- Ligands: 01.26
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.485, C:L.485, C:L.505
R16.19: 5 residues within 4Å:- Chain B: Q.532
- Chain D: L.485, L.505, S.506
- Ligands: 01.32
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.485, D:L.485, D:L.505
R16.20: 6 residues within 4Å:- Chain B: L.485, S.504, L.505, S.506
- Chain C: Q.532
- Ligands: 01.18
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.505
- 4 x HEX: HEXANE(Non-covalent)
HEX.9: 1 residues within 4Å:- Chain D: L.537
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.537
HEX.16: 1 residues within 4Å:- Chain C: L.537
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.537
HEX.24: 1 residues within 4Å:- Chain A: L.537
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.537
HEX.30: 1 residues within 4Å:- Chain B: L.537
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.537
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
EUJ.10: 13 residues within 4Å:- Chain A: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:L.359
- Hydrogen bonds: A:Y.95, A:K.103, A:C.112, A:K.113, A:R.366, A:R.366, A:S.367, A:S.367
- Salt bridges: A:K.103, A:K.107, A:R.109, A:K.113, A:K.113, A:R.366, A:R.366, A:R.370, A:R.451
EUJ.17: 13 residues within 4Å:- Chain B: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:L.359
- Hydrogen bonds: B:Y.95, B:K.103, B:C.112, B:K.113, B:R.366, B:R.366, B:S.367, B:S.367
- Salt bridges: B:K.103, B:K.107, B:R.109, B:K.113, B:K.113, B:R.366, B:R.366, B:R.370, B:R.451
EUJ.25: 13 residues within 4Å:- Chain C: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
18 PLIP interactions:18 interactions with chain C- Hydrophobic interactions: C:L.359
- Hydrogen bonds: C:Y.95, C:K.103, C:C.112, C:K.113, C:R.366, C:R.366, C:S.367, C:S.367
- Salt bridges: C:K.103, C:K.107, C:R.109, C:K.113, C:K.113, C:R.366, C:R.366, C:R.370, C:R.451
EUJ.31: 13 residues within 4Å:- Chain D: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
18 PLIP interactions:18 interactions with chain D- Hydrophobic interactions: D:L.359
- Hydrogen bonds: D:Y.95, D:K.103, D:C.112, D:K.113, D:R.366, D:R.366, D:S.367, D:S.367
- Salt bridges: D:K.103, D:K.107, D:R.109, D:K.113, D:K.113, D:R.366, D:R.366, D:R.370, D:R.451
- 4 x 01: 4-[[(3R)-3-[1-(4-chloranyl-2-fluoranyl-phenyl)piperidin-4-yl]-3-methyl-2H-indol-1-yl]sulfonyl]-N,N-dimethyl-benzenesulfonamide
01.11: 17 residues within 4Å:- Chain A: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Chain D: L.540, Q.543, Y.547, S.551, Y.555
- Ligands: R16.8
6 PLIP interactions:2 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:Y.547, D:Y.547, A:V.480, A:V.480, A:Y.484, A:F.513
01.18: 17 residues within 4Å:- Chain B: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Chain C: L.540, Q.543, Y.547, S.551, Y.555
- Ligands: R16.20
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:V.480, B:V.480, B:Y.484, B:F.513, C:Y.547, C:Y.547
01.26: 17 residues within 4Å:- Chain A: L.540, Q.543, Y.547, S.551, Y.555
- Chain C: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Ligands: R16.12
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:V.480, C:V.480, C:Y.484, C:F.513, A:Y.547, A:Y.547
01.32: 17 residues within 4Å:- Chain B: L.540, Q.543, Y.547, S.551, Y.555
- Chain D: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Ligands: R16.19
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain B- Hydrophobic interactions: D:V.480, D:V.480, D:Y.484, D:F.513, B:Y.547, B:Y.547
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x LNK: PENTANE(Non-covalent)
- 8 x OCT: N-OCTANE(Non-covalent)
- 4 x R16: HEXADECANE(Non-covalent)
- 4 x HEX: HEXANE(Non-covalent)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
- 4 x 01: 4-[[(3R)-3-[1-(4-chloranyl-2-fluoranyl-phenyl)piperidin-4-yl]-3-methyl-2H-indol-1-yl]sulfonyl]-N,N-dimethyl-benzenesulfonamide
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
D - Membrane
-
We predict this structure to be a membrane protein.